Shanghai Xiao Fang Pharmaceutical Co (SHSE:603207) FCF Margin %: -7.39% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603207 Shanghai Xiao Fang Pharmaceutical Co Ltd SHSE:603207
38 GF Score
Price ¥21.87
! 2 Warning Signs
View Full Analysis

What is Shanghai Xiao Fang Pharmaceutical Co FCF Margin %?

Shanghai Xiao Fang Pharmaceutical Co SHSE:603207 +1.72% 38 FCF Margin % is -7.39% as of Mar. 2026. GuruFocus rates SHSE:603207 with a GF Score™ of 38/100. The stock has 2 warning signs investors should review. Among 963 Drug Manufacturers companies, Shanghai Xiao Fang Pharmaceutical Co ranks better than 77.57% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Shanghai Xiao Fang Pharmaceutical Co's Free Cash Flow for the three months ended in Mar. 2026 was ¥-10.8 Mil. Shanghai Xiao Fang Pharmaceutical Co's Revenue for the three months ended in Mar. 2026 was ¥145.7 Mil. Therefore, Shanghai Xiao Fang Pharmaceutical Co's FCF Margin % for the quarter that ended in Mar. 2026 was -7.39%.

As of today, Shanghai Xiao Fang Pharmaceutical Co's current FCF Yield % is 2.01%.

The historical rank and industry rank for Shanghai Xiao Fang Pharmaceutical Co's FCF Margin % or its related term are showing as below:

SHSE:603207' s FCF Margin % Range Over the Past 10 Years
Min: 13.03   Med: 27.03   Max: 43.22
Current: 13.03


During the past 7 years, the highest FCF Margin % of Shanghai Xiao Fang Pharmaceutical Co was 43.22%. The lowest was 13.03%. And the median was 27.03%.

SHSE:603207's FCF Margin % is ranked better than
77.57% of 963 companies
in the Drug Manufacturers industry
Industry Median: 2.57 vs SHSE:603207: 13.03


Shanghai Xiao Fang Pharmaceutical Co FCF Margin % Related Terms


Shanghai Xiao Fang Pharmaceutical Co FCF Margin % Historical Data

* Premium members only.

The historical data trend for Shanghai Xiao Fang Pharmaceutical Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Xiao Fang Pharmaceutical Co FCF Margin % Chart

Shanghai Xiao Fang Pharmaceutical Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial 41.57 16.55 25.45 27.03 20.29

Shanghai Xiao Fang Pharmaceutical Co Quarterly Data
Dec19 Dec20 Dec21 Mar22 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.50 24.26 20.01 16.99 -7.39

SHSE:603207 vs ZTS: FCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Xiao Fang Pharmaceutical Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Xiao Fang Pharmaceutical Co FCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai Xiao Fang Pharmaceutical Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Shanghai Xiao Fang Pharmaceutical Co's FCF Margin % falls into.


SHSE:603207
38GF Score
Shanghai Xiao Fang Pharmaceutical Co Ltd SHSE:603207
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Xiao Fang Pharmaceutical Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Shanghai Xiao Fang Pharmaceutical Co's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=106.557/525.281
=20.29 %

Shanghai Xiao Fang Pharmaceutical Co's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-10.766/145.694
=-7.39 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -7.39% mean?
Shanghai Xiao Fang Pharmaceutical Co (SHSE:603207) has a FCF Margin % of -7.39% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Shanghai Xiao Fang Pharmaceutical Co and its competitors. Over the past decade, Shanghai Xiao Fang Pharmaceutical Co's FCF Margin % has ranged from 13.03 to 43.22. According to the industry distribution chart, Shanghai Xiao Fang Pharmaceutical Co ranks #216 out of 963 companies in the Drug Manufacturers industry, placing it in the top 22.4%.
Is Shanghai Xiao Fang Pharmaceutical Co's FCF Margin % too high?
Shanghai Xiao Fang Pharmaceutical Co's current FCF Margin % is -7.39%. Over the past 10 years, this metric has ranged from a low of 13.03 to a high of 43.22. Based on the distribution chart, Shanghai Xiao Fang Pharmaceutical Co ranks #216 out of 963 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Shanghai Xiao Fang Pharmaceutical Co has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Shanghai Xiao Fang Pharmaceutical Co's FCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Shanghai Xiao Fang Pharmaceutical Co ranks #216 out of 963 companies for FCF Margin %. This places Shanghai Xiao Fang Pharmaceutical Co in the top 22% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 2.57. Historically, Shanghai Xiao Fang Pharmaceutical Co's own FCF Margin % has ranged from 13.03 to 43.22 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.57, based on 963 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Shanghai Xiao Fang Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Xiao Fang Pharmaceutical Co's current FCF Margin % is -7.39%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Xiao Fang Pharmaceutical Co stock overvalued right now?
Shanghai Xiao Fang Pharmaceutical Co (SHSE:603207) has a current FCF Margin % of -7.39%. The current FCF Margin % is -7.39%. Shanghai Xiao Fang Pharmaceutical Co's overall GF Score™ is 38/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Shanghai Xiao Fang Pharmaceutical Co (SHSE:603207), the current FCF Margin % is -7.39% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Shanghai Xiao Fang Pharmaceutical Co Business Description

Address No. 777, Hongzhu Road, Fengxian District, Shanghai, CHN, 201411
Shanghai Xiao Fang Pharmaceutical Co Ltd is engaged in Research and development, production and sales of topical medicines.
38GF Score

Get the complete analysis for SHSE:603207

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥21.87
Price